CAS 114977-28-5

Taxotere

Descripción:

Taxotere, con el número CAS 114977-28-5, es un agente quimioterapéutico utilizado principalmente en el tratamiento de varios tipos de cáncer, incluyendo cáncer de mama, pulmón y próstata. Su ingrediente activo es el docetaxel, que es un derivado semisintético del paclitaxel. Taxotere actúa como un inhibidor de microtúbulos, interrumpiendo la función normal del huso mitótico durante la división celular, inhibiendo así la proliferación de células cancerosas. La sustancia se administra típicamente por vía intravenosa y es conocida por su efectividad en combinación con otros agentes quimioterapéuticos. Taxotere se caracteriza por su solubilidad en disolventes orgánicos y su formulación a menudo incluye polisorbato 80 para mejorar la solubilidad en soluciones acuosas. Los efectos secundarios comunes asociados con Taxotere incluyen neutropenia, fatiga, náuseas y alopecia, entre otros. Debido a sus potentes efectos, se clasifica como un agente antineoplásico y está sujeto a un cuidadoso monitoreo durante el tratamiento para gestionar posibles reacciones adversas.

Fórmula: C₄₃H₅₃NO₁₄

InChI: InChI=1/C43H53NO14/c1-22-26(55-37(51)32(48)30(24-15-11-9-12-16-24)44-38(52)58-39(3,4)5)20-43(53)35(56-36(50)25-17-13-10-14-18-25)33-41(8,34(49)31(47)29(22)40(43,6)7)27(46)19-28-42(33,21-54-28)57-23(2)45/h9-18,26-28,30-33,35,46-48,53H,19-21H2,1-8H3,(H,44,52)/t26-,27-,28+,30-,31+,32+,33-,35-,41-,42-,43+/m0/s1

Clave InChI: InChIKey=ZDZOTLJHXYCWBA-VCVYQWHSSA-N

SMILES: O(C(C)=O)[C@]12[C@]3([C@H](OC(=O)C4=CC=CC=C4)[C@@]5(O)C(C)(C)C([C@@H](O)C(=O)[C@]3(C)[C@@H](O)C[C@]1(OC2)[H])=C(C)[C@@H](OC([C@@H]([C@@H](NC(OC(C)(C)C)=O)C6=CC=CC=C6)O)=O)C5)[H]

Sinónimos:

• (1beta,2alpha,5beta,7beta,10beta,13alpha)-4-(acetyloxy)-13-({(2R,3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-3-phenylpropanoyl}oxy)-1,7,10-trihydroxy-9-oxo-5,20-epoxytax-11-en-2-yl benzoate
• (2alpha,5beta,7beta,10beta,13alpha)-4-(acetyloxy)-13-({(2R,3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-3-phenylpropanoyl}oxy)-1,7,10-trihydroxy-9-oxo-5,20-epoxytax-11-en-2-yl benzoate
• (2alpha,5beta,7beta,10beta,13alpha)-4-(acetyloxy)-13-({(3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-3-phenylpropanoyl}oxy)-1,7,10-trihydroxy-9-oxo-5,20-epoxytax-11-en-2-yl benzoate
• 7,11-Methano-1H-cyclodeca[3,4]benz[1,2-b]oxete, benzenepropanoic acid deriv.
• Ati 1123
• Benzenepropanoic acid, β-[[(1,1-dimethylethoxy)carbonyl]amino]-α-hydroxy-, (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,6,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester, (αR,βS)-
• Benzenepropanoic acid, β-[[(1,1-dimethylethoxy)carbonyl]amino]-α-hydroxy-, 12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,6,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester, [2aR-[2aα,4β,4aβ,6β,9α(αR*,βS*),11α,12α,12aα,12bα]]-
• Bind-014
• Ckd 810
• Crlx 301
• Decetaxel anhydrous
• Docefrez
• Docetaxel
• Docetaxel Anhydrous
• Docetaxol
• Docetere
• Duopafei
• Miradocetaxel
• N-Debenzoyl-N-tert-butoxycarbonyl-10-deacetyltaxol
• N-debenzoyl-N-tert-butoxycarbonyl-10-deacetyl taxol
• Rp 56976
• Sid 530
• Taxotel
• docetaxcel，DTX
• )benz(1,2-b)oxet-9-ylester,(2ar-(2a-alpha,4-beta,4a-beta,6-beta,9-alpha(alph
• TAXOTERE
• DOCETAXEL (TAXOTERE)
• Docetaxel9.5%
• Benzenepropanoic acid, b-[[(1,1-dimethylethoxy)carbonyl]amino]-a-hydroxy-, (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,6,11-trih
• Docetaxel99.5%
• DOCETAXEL TRIHYDRATE
• DocetaxelAnhydrous/Trihydrate
• beta-s*),11-alpha,12-alpha,12a-alpha,12b-alpha))-a-r
• n-debenzoyl-n-(tert-butoxycarbonyl)taxol
• o-4,6,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1h-cyclodeca(3,4
• rp56976
• DocetaxelAnhydrousin-HouseStandard
• benzenepropanoicacid,beta-(((1,1-dimethylethoxy)carbonyl)amino)-alpha-hydroxy
• DOCETAXEL ANHYDROUS 99.5%
• -,12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydr

Docetaxel

CAS: 114977-28-5

Fórmula: C₄₃H₅₃NO₁₄

Pureza: >98.0%(HPLC)

Forma y color: White to Almost white powder to crystal

Peso molecular: 807.89

Ref: 3B-D4102

Docetaxel, 99%

CAS: 114977-28-5

Docetaxel, 114977-28-5, is a taxoid antineoplastic agent and a second-generation cytotoxic antimicrotubule agent. Learn more at Thermo Fisher Scientific.

Fórmula: C₄₃H₅₃NO₁₄

Pureza: 99%

Peso molecular: 807.89

Ref: 02-J60174

ANHYDROUS DOCETAXEL CRS

CAS: 114977-28-5

ANHYDROUS DOCETAXEL CRS

Fórmula: C₄₃H₅₃NO₁₄

Forma y color: Crystalline Powder. White. Powder.

Peso molecular: 807.8792

Ref: 41-Y0001466

Docetaxel

CAS: 114977-28-5

Docetaxel (RP-56976) is a semi-synthetic analog of paclitaxel, a microtubule depolymerization inhibitor (IC50=0.2 μM).

Fórmula: C₄₃H₅₃NO₁₄

Pureza: 98.6% - 99.29%

Forma y color: White Solid

Peso molecular: 807.88

Ref: TM-T1034

Docetaxel

CAS: 114977-28-5

Fórmula: C₄₃H₅₃NO₁₄

Pureza: 98%

Forma y color: Solid

Peso molecular: 807.8792

Ref: IN-DA0039I1

Docetaxel

CAS: 114977-28-5

Fórmula: C₄₃H₅₃NO₁₄

Forma y color: White To Off-White Solid

Peso molecular: 807.89

Ref: 4Z-D-191

Docetaxel

CAS: 114977-28-5

Fórmula: C₄₃H₅₃NO₁₄·xH₂O

Pureza: ≤ 0.1%

Forma y color: White to off-white crystalline powder

Peso molecular: 807.88 (anhydrous)

Ref: 7W-GP5102

Docetaxel

CAS: 114977-28-5

Docetaxel

Fórmula: C₄₃H₅₃NO₁₄

Pureza: >99%

Forma y color: White Solid-Powder

Peso molecular: 807.87922

Ref: 54-BID2710

Docetaxel

CAS: 114977-28-5

Docetaxel is an antineoplastic drug by inhibiting microtubule depolymerization, and attenuating of the effects of bcl-2 and bcl-xL gene expression.

Fórmula: C₄₃H₅₃NO₁₄

Pureza: 95%~99%

Peso molecular: 807.89

Ref: BP-BP0514

Docetaxel Anhydrous

Producto controlado

CAS: 114977-28-5

Fórmula: C₄₃H₅₃NO₁₄

Forma y color: Neat

Peso molecular: 807.88

Ref: 86-MM3390.00

Docetaxel

CAS: 114977-28-5

Fórmula: C₄₃H₅₃NO₁₄

Peso molecular: 807.89

Ref: ST-EA-CP-D32000

Docetaxel

CAS: 114977-28-5

Applications Docetaxel is an antimitotic Taxol analog antibiotic.

Fórmula: C₄₃H₅₃NO₁₄

Forma y color: Neat

Peso molecular: 807.88

Ref: TR-D525623

Docetaxel - Bio-X ™

CAS: 114977-28-5

Docetaxel is an antineoplastic agent that is used to treat various cancers such as breast and prostate cancer. This drug interferes with the normal function of microtubule growth. It is an anti-mitotic drug used in chemotherapy. Research has shown that this drug also induces programmed cell death in cancer cells.

Fórmula: C₄₃H₅₃NO₁₄

Pureza: Min. 90 Area-%

Forma y color: White/Off-White Solid

Peso molecular: 807.88 g/mol

Ref: 3D-BD164373

Docetaxel

CAS: 114977-28-5

A cytotoxic taxane and anti-microtubule agent with anti-proliferative activity. Docetaxel binds to the β-subunit of tubulin, which results in increased polymerisation and stabilisation of microtubules. The compound interferes with microtubule dynamics, which leads to the cell cycle arrest in the G2/M phase and apoptosis. The compound has significant inhibitory activity in solid tumors either alone or in combination with other chemotherapeutic agents.

Fórmula: C₄₃H₅₃NO₁₄

Pureza: Min. 98 Area-%

Forma y color: White Powder

Peso molecular: 807.88 g/mol

Ref: 3D-FD10817

Docetaxel

CAS: 114977-28-5

Ref: BE-MU-7336

Docetaxel

CAS: 114977-28-5

Ref: BE-RMCD202000